In the past week, the Therapeutic Solutions International (OTCMKTS:TSOI) stock has been in the middle of a strong rally and managed to deliver gains of as much as 23% amidst heavy interest. In light of such considerable gains, it may be a good time for investors to consider taking a closer look at the company.
Market Action
On Thursday, TSOI stock moved up 3.54% to $0.0234 with 5.20 million shares, compared to its average volume of 8.42 million shares. The stock moved within a range of $0.0201 – 0.0250 after opening trade at $0.0201.
Therapeutic Solutions International Granted Second United States Patent on QuadraMune® for Prevention, Inhibition, and Treatment of COVID-19
As a matter of fact, the company was actually in the news yesterday after it announced that it had been issued a United States Patent that is titled “Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19.”It goes without saying that it was another significant milestone for the company and it is going to be interesting to see if the stock can actually continue to add to its gains today.
The patent is related to the composition of matter and is also concerned with QuadraMune for the purpose of preventing as well as treating COVID 19 infection. In this context, it is perhaps also necessary to note that Therapeutic Solutions had also been granted patents of similar nature in the past. Hence, it can be concluded that the company has managed to build up a strong portfolio of patents.
Key Quote
“The validation of QuadraMune’s science by the granting of two United States Patents speaks volumes to the potential and science behind our commercially available nutraceutical product,” said Dr. Thomas Ichim, Board Member of the Company and Co-Inventor. “To my knowledge this is the first natural immune modulator which works through inhibition of the indolamine 2,3 deoxygenase pathway that has received patent protection.”
Traders Note
TSOI stock is trading below the 50-Day and 200-Day Moving averages of $0.0242 and $0.0429 respectively. Moreover, the stock is trading is the oversold zone with RSI stands at 50.
 Stock Soars: Company New Patent){kind=link}